These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11879660)

  • 21. Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) Investigators.
    Teo KK; Burton JR; DeAlmeida J; Dolezsar S; Montague PA; Dzavik V; Tymchak WJ; Taylor DA; Montague TJ
    Can J Cardiol; 1997 Apr; 13(4):363-9. PubMed ID: 9141968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up.
    Nadjiri J; Hausleiter J; Jähnichen C; Will A; Hendrich E; Martinoff S; Hadamitzky M
    J Cardiovasc Comput Tomogr; 2016; 10(2):97-104. PubMed ID: 26837235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography.
    Kang J; Park KW; Lee MS; Zheng C; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):130. PubMed ID: 29954346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry.
    Van Belle E; Rioufol G; Pouillot C; Cuisset T; Bougrini K; Teiger E; Champagne S; Belle L; Barreau D; Hanssen M; Besnard C; Dauphin R; Dallongeville J; El Hahi Y; Sideris G; Bretelle C; Lhoest N; Barnay P; Leborgne L; Dupouy P;
    Circulation; 2014 Jan; 129(2):173-85. PubMed ID: 24255062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
    Watts GF; Pang J; Chan DC; Brunt JNH; Lewis B
    Atherosclerosis; 2016 Sep; 252():82-87. PubMed ID: 27508319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial quantitative coronary angiography and coronary events.
    Mack WJ; Xiang M; Selzer RH; Hodis HN
    Am Heart J; 2000 Jun; 139(6):993-9. PubMed ID: 10827379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A direct comparison of intravascular ultrasound and quantitative coronary arteriography: implications for measures of atherosclerosis as clinical surrogates.
    Brown BG
    Circulation; 2007 Apr; 115(14):1824-6. PubMed ID: 17420360
    [No Abstract]   [Full Text] [Related]  

  • 29. Studying coronary plaque regression with IVUS: a critical review of recent studies.
    Carlier SG; Tanaka K
    J Interv Cardiol; 2006 Feb; 19(1):11-5. PubMed ID: 16483334
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials.
    Gibson CM; Sandor T; Stone PH; Pasternak RC; Rosner B; Sacks FM
    Am J Cardiol; 1992 May; 69(16):1286-90. PubMed ID: 1585861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiographic regression of coronary atheromatosis].
    Szamosi A
    Lakartidningen; 1991 Apr; 88(15):1365-7. PubMed ID: 2020234
    [No Abstract]   [Full Text] [Related]  

  • 32. Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?
    Brown BG; Zhao XQ
    J Am Coll Cardiol; 2007 Mar; 49(9):933-8. PubMed ID: 17336715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR
    Chinnaiyan KM; Akasaka T; Amano T; Bax JJ; Blanke P; De Bruyne B; Kawasaki T; Leipsic J; Matsuo H; Morino Y; Nieman K; Norgaard BL; Patel MR; Pontone G; Rabbat M; Rogers C; Sand NP; Raff G
    J Cardiovasc Comput Tomogr; 2017; 11(1):62-67. PubMed ID: 28017291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
    Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
    Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis?
    von Birgelen C; Slager CJ; Di Mario C; de Feyter PJ; Serruys PW
    Atherosclerosis; 1995 Dec; 118 Suppl():S103-13. PubMed ID: 8821470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
    Marchioli R; Prieto JC; Tognoni G
    Clin Trials Metaanal; 1994 Oct; 29(2-3):139-76. PubMed ID: 10150224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis.
    De Franco AC; Nissen SE
    Am J Cardiol; 2001 Nov; 88(10A):7M-20M. PubMed ID: 11705417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can life-style changes reverse coronary atherosclerosis?
    Ornish D
    Hosp Pract (Off Ed); 1991 May; 26(5):123-6, 129-32. PubMed ID: 2030112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.